0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Counterpoint to 'Pneumococcal Vaccine After 1 5 Years of Use'

Frederick L. Ruben, MD
Arch Intern Med. 1995;155(7):771-772. doi:10.1001/archinte.1995.00430070131015.
Text Size: A A A
Published online

The recent article on pneumococcal vaccine published in the Archives1 provides an unbalanced viewpoint on the issues of the efficacy and use of pneumococcal vaccine in the United States. The authors omit critical information from their discussion of the literature that would greatly weaken their conclusions regarding who the evidence warrants vaccinating.

In their introduction, Hirschmann and Lipsky state "the only American population tested with a modern vaccine before approval of the Food and Drug Administration was..."1 and mention the study by Amman et al.2 This is incorrect, since the trials at Kaiser-Permanente and Dorothea Dix3 were conducted well before the approval was given in 1977. One can refute the authors' assertion that the studies of MacLeod et al4 were not relevant, since these studies used polyvalent purified capsular polysaccharides, virtually identical to the ones in use today, but with fewer serotypes included in the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();